Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer and is a fast progressive disease when left untreated. Identification of potential biomarkers in NSCLC is an ongoing area of research that aims to detect, diagnose, and prognosticate patients early to optimize treatment. We review th...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Jason Hongting, Ng, Benjamin, Lim, Wei-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318853/
https://www.ncbi.nlm.nih.gov/pubmed/35883698
http://dx.doi.org/10.3390/cells11142257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318853/
https://www.ncbi.nlm.nih.gov/pubmed/35883698
http://dx.doi.org/10.3390/cells11142257

Ejemplares similares